.png){kind=icon}
返回
Study Protocol: The Heart and Brain Study
.png){kind=icon}
OA
AI
DOI：10.3389/fphys.2021.643725.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Background It is well-established that what is good for the heart is good for the brain. Vascular factors such as hypertension, diabetes, and high cholesterol, and genetic factors such as the apolipoprotein E4 allele increase the risk of developing both cardiovascular disease and dementia. However, the mechanisms underlying the heart-brain association remain unclear. Recent evidence suggests that impairments in vascular phenotypes and cerebrovascular reactivity (CVR) may play an important role in cognitive decline. The Heart and Brain Study combines state-of-the-art vascular ultrasound, cerebrovascular magnetic resonance imaging (MRI) and cognitive testing in participants of the long-running Whitehall II Imaging cohort to examine these processes together. This paper describes the study protocol, data pre-processing and overarching objectives. Methods and Design The 775 participants of the Whitehall II Imaging cohort, aged 65 years or older in 2019, have received clinical and vascular risk assessments at 5-year-intervals since 1985, as well as a 3T brain MRI scan and neuropsychological tests between 2012 and 2016 (Whitehall II Wave MRI-1). Approximately 25% of this cohort are selected for the Heart and Brain Study, which involves a single testing session at the University of Oxford (Wave MRI-2). Between 2019 and 2023, participants will undergo ultrasound scans of the ascending aorta and common carotid arteries, measures of central and peripheral blood pressure, and 3T MRI scans to measure CVR in response to 5% carbon dioxide in air, vessel-selective cerebral blood flow (CBF), and cerebrovascular lesions. The structural and diffusion MRI scans and neuropsychological battery conducted at Wave MRI-1 will also be repeated. Using this extensive life-course data, the Heart and Brain Study will examine how 30-year trajectories of vascular risk throughout midlife (40-70 years) affect vascular phenotypes, cerebrovascular health, longitudinal brain atrophy and cognitive decline at older ages. Discussion The study will generate one of the most comprehensive datasets to examine the longitudinal determinants of the heart-brain association. It will evaluate novel physiological processes in order to describe the optimal window for managing vascular risk in order to delay cognitive decline. Ultimately, the Heart and Brain Study will inform strategies to identify at-risk individuals for targeted interventions to prevent or delay dementia.
Keyword:
ageing
MRI
cerebrovascular reactivity
cognition
dementia prevention
longitudinal cohort
ultrasound
heart-brain
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.4
论文数:
2.0W
被引数:
6.2W
机构
引用论文
Association of Midlife Cardiovascular Risk Profiles With Cerebral Perfusion at Older Ages.png)
JAMA NETWORK OPENOAAI
JAMA NETWORK OPENIF9.7
OAAI分享收藏Three-Dimensional Graphene/MnO2Nanowalls Hybrid for High-Efficiency Electrochemical Supercapacitors用于高效电化学超级电容器的三维石墨烯/MnO2 纳米壁混合物Nano
NanoIF0
PREAI
分享收藏Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling使用动脉自旋标记定量急性中风中的连续脑血流量STROKEOAAI
STROKEIF8.9
OAAI分享收藏The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment蒙特利尔认知评估，MoCA:: 轻度认知障碍的简短筛查工具
PREAI
分享收藏
查看更多内容